Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-10-01
Series:Pharmaceuticals
Assuntos:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Acceso en liña:https://www.mdpi.com/1424-8247/13/10/324
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares